Nuclear Medicine and Preclinical Imaging Systems
For all enquiries: +61 415327620

About Mediso

Mediso (located at Budapest, Hungary) is one of the World’s largest suppliers of various medical diagnostic and research, single and multi-modality imaging devices. The company was founded in 1990 by leading experts whom had been working in the largest nuclear equipment development and production company in Europe which had been in existence since 1960.

The company offers complete solutions from hardware design to evaluation and quantification software both for clinical patient care and high-level life science research. Beyond simply manufacturing and selling imaging devices, Mediso is involved in research and R&D with many partners world wide. This involvement ensures that Mediso is continually in contact with what the medical and research community needs and can respond accordingly. Additionally, Mediso becomes the common bond that unites a whole world of researchers and medical practitioners to achieve the highest level of expertise for all people concerned by sharing their knowledge base.

Besides a unique 3-modality clinical SPECT-CT-PET hybrid system, Mediso launched the world’s first preclinical integrated PET/MRI and SPECT/MRI system as members of the nanoScan® high-end small animal imager family which consists of SPECT/MRI, PET/MRI, SPECT/CT and PET/CT products. Mediso products are sold worldwide directly and through a network of distributors. There are more than 1000 imaging systems operating in more than 85 countries around the world.


Clinical Diagnostics and CRO Partners

Mediso developed special partnerships with preclinical imaging contract research organizations and leading molecular imaging centers in both preclinical and clinical domain around the world. Our cooperation with CROmed, Karolinska Institute, Semmelweis University in preclinical field and Scanomed, University of Debrecen Medical School and Hungarian National Institute of Neuroscience in clinical area represent vital drive to Mediso’s developments as well as invaluable feedback and better insight into users’ needs.


Customer focused support

Mediso-affiliated subsidiaries and world-wide distributor network with strong factory support ensure close contact with our customers and quick, professional response to their requests not only in technical but also in application related issues. We at Mediso are proud to serve physicians and researchers at sites with more than 100 preclinical and 900 clinical installed systems in 86 countries.

  • 86 countries
  • 100+ preclinical systems
  • 900+ clinical systems

In four countries Mediso is represented through its own subsidiaries. Mediso Polska in Poland was founded in 1996. Mediso GmbH in Germany started its sales and service activity in March 2005.  Both Mediso USA in Boston and Mediso Pacific in Sydney, Australia started in 2012.

In 60 further countries worldwide Mediso is represented by local companies, who have several years of experience in sales and service in nuclear medicine. For further information about your local business partner please contact Mediso Ltd. through any of the available channels.


2012   Frost & Sullivan 2012 European Preclinical Imaging New Product Innovation Award

2012   Launch of nanoScan® Family complete preclinical SPECT/PET/CT/MRI imager portfolio

2011   Launch of nanoScan® preclinical PET/MRI

2011   Grand prize of innovation 2010 (NanoPET™ /CT)

2010   Introduction and installation of AnyScan® SC ”CT-FIRST” CT/SPECT units

2009   Inauguration of Mediso Reference Multimodality Diagnostic, Research & Training Centre

2009   New Mediso product the NanoPET/CT™ preclinical PET-CT

2008   Frost & Sullivan 2008 European Medical Imaging Entrepreneurial Company of the Year Award

2008   Launching of AnyScan® the first real triple-modality human SPECT-CT-PET of the world

2007   Mediso takes the Nuclear Medicine clinical diagnostic service profile acquiring of PET-CT Ltd.

2007   Production of the first Mediso human SPECT/CT

2006   Grand Prize of Innovation 2006 (NanoSPECT/CT®)

2006   Manufacturing of the first Mediso preclinical SPECT/CT

2000   ISO 13485 certification of the company

2000   ISO 9001 and MDD certification of the company

2000   Launching the Nucline™ SPIRIT DH-V variable angle dual head camera

1998   Special Prize of the President of Hungary (X-Ring-R)

1998   Mediso acquired the Nuclear Medicine Branch of Gamma Works, the dominant experts joined Mediso

1996   Release of the first SPECT camera Nucline™ X-Ring-R

1994   Manufacturing of the first Mediso gamma camera

1990   Foundation of Mediso Medical Imaging Systems


1972   Gamma Works released its first Nuclear Medicine imager with digital processing

1960  Gamma works forms nuclear equipment manufacturing profile

1943  George Hevesy receives Nobel Price for developing the theory of In Vivo Tracer Techniques

1920  Foundation of Gamma Works